| An integrated in silico screening strategy for identifying promising disruptors of p53-MDM2 interaction H Sirous, G Chemi, G Campiani, S Brogi Computational Biology and Chemistry 83, 107105, 2019 | 43 | 2019 |
| Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using in silico Structure-Based Combinatorial Library Design … H Sirous, G Chemi, S Gemma, S Butini, Z Debyser, F Christ, L Saghaie, ... Frontiers in Chemistry 7, 574, 2019 | 37 | 2019 |
| In vitro and in silico studies of the inhibitory effects of some novel kojic acid derivatives on tyrosinase enzyme A Asadzadeh, H Sirous, M Pourfarzam, P Yaghmaei, F Afshin Iranian journal of basic medical sciences 19 (2), 132, 2016 | 36 | 2016 |
| Amyloid β fibril disruption by oleuropein aglycone: long-time molecular dynamics simulation to gain insight into the mechanism of action of this polyphenol from extra virgin … S Brogi, H Sirous, V Calderone, G Chemi Food & function 11 (9), 8122-8132, 2020 | 26 | 2020 |
| Discovery of novel hit compounds as potential HDAC1 inhibitors: The case of ligand-and structure-based virtual screening H Sirous, G Campiani, V Calderone, S Brogi Computers in biology and medicine 137, 104808, 2021 | 22 | 2021 |
| Synthesis, Molecular Modelling and Biological Studies of 3-hydroxypyrane-4-one and 3-hydroxy-pyridine-4-one Derivatives as HIV-1 Integrase Inhibitors H Sirous, A Fassihi, S Brogi, G Campiani, F Christ, Z Debyser, S Gemma, ... Medicinal Chemistry 15 (7), 755-770, 2019 | 22 | 2019 |
| Computer-driven development of an in silico tool for finding selective histone deacetylase 1 inhibitors H Sirous, G Campiani, S Brogi, V Calderone, G Chemi Molecules 25 (8), 1952, 2020 | 18 | 2020 |
| Design, synthesis and anti-HIV-1 evaluation of a series of 5-hydroxypyridine-4-one derivatives as possible integrase inhibitors M Rostami, H Sirous, R Zabihollahi, MR Aghasadeghi, SM Sadat, ... Medicinal Chemistry Research 24, 4113-4127, 2015 | 11 | 2015 |
| Docking studies of some 5-hydroxypyridine-4-one derivatives: evaluation of integrase and ribonuclease H domain of reverse transcriptase as possible targets for anti-HIV-1 activity H Sirous, R Zabihollahi, MR Aghasadeghi, SM Sadat, L Saghaie, ... Medicinal Chemistry Research 24, 2195-2212, 2015 | 8 | 2015 |
| Monastrol derivatives: in silico: and: in vitro: cytotoxicity assessments Z Bidram, H Sirous, GA Khodarahmi, F Hassanzadeh, N Dana, AA Hariri, ... Research in Pharmaceutical Sciences 15 (3), 249-262, 2020 | 7 | 2020 |
| Expression analysis of HIF-3α as a potent prognostic biomarker in various types of human cancers: a case of meta-analysis B Yazdani, H Sirous Research in Pharmaceutical Sciences 17 (5), 508-526, 2022 | 4 | 2022 |
| Discovery of novel direct small-molecule inhibitors targeting HIF-2α using structure-based virtual screening, molecular dynamics simulation, and MM-GBSA calculations B Yazdani, H Sirous, FJ Enguita, S Brogi, PAC Wing, A Fassihi Molecular Diversity, 1-22, 2023 | 3 | 2023 |
| HIF3A: a potent prognostic biomarker in different kinds of cancer B Yazdani, H Sirous Preprints, 2021 | 3 | 2021 |
| In Silico Identification of Natural Products and World-Approved Drugs Targeting the KEAP1/NRF2 Pathway Endowed with Potential Antioxidant Profile S Brogi, I Guarino, L Flori, H Sirous, V Calderone Computation 11 (12), 255, 2023 | 2 | 2023 |
| Integrative bioinformatics analysis of ACS enzymes as candidate prognostic and diagnostic biomarkers in colon adenocarcinoma E Parsazad, F Esrafili, B Yazdani, S Ghafarzadeh, N Razmavar, H Sirous Research in Pharmaceutical Sciences 18 (4), 413-429, 2023 | 2 | 2023 |
| Disruption of Irisin Dimerization by FDA-Approved Drugs: A Computational Repurposing Approach for the Potential Treatment of Lipodystrophy Syndromes L Flori, S Brogi, H Sirous, V Calderone International Journal of Molecular Sciences 24 (8), 7578, 2023 | 2 | 2023 |
| New amide and diterpene alkaloids with anticholinesterase activity from Delphinium cyphoplectrum roots A Salehi, B Zolfaghari, M Aghaei, H Sirous, M Sadeghi, MR Gholami, ... DARU Journal of Pharmaceutical Sciences, 1-15, 2024 | 1 | 2024 |
| Structure-based high-throughput virtual screening and molecular dynamics simulation for the discovery of novel SARS-CoV-2 NSP3 Mac1 domain inhibitors B Yazdani, H Sirous, S Brogi, V Calderone Viruses 15 (12), 2291, 2023 | 1 | 2023 |
| Preparing a database of corrected protein structures important in cell signaling pathways S Hatami, H Sirous, K Mahnam, A Najafipour, A Fassihi Research in Pharmaceutical Sciences 18 (1), 67-78, 2023 | 1 | 2023 |
| Design, synthesis, and cytotoxicity evaluation of novel indole-acylhydrazone derivatives of 4-pyridinone as potential histone deacetylase-2 inhibitors N Naghi-Ganji, L Saghaei, F Tavakoli, V Azimian, M Mirian, H Sirous, ... Research in Pharmaceutical Sciences 17 (5), 572-584, 2022 | 1 | 2022 |
SIMONE BROGIAssociate Professor of Pharmacology at Department of Pharmacy, University of Pisa, ItalyVerified email at unipi.it
